TITLE

Fat Funding: $18 Million for Cellulite

PUB. DATE
July 2008
SOURCE
Red Herring;7/16/2008, p1
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article reports on the $18 million investment secured by cellulite startup Eleme Medical in 2008. The investment came from Hambrecht & Quist Capital Management and L Capital Partners. Eleme plans to allocate the investment for the commercialization of its SmoothShapes cellulite treatment and the development of other cellulite products.
ACCESSION #
36670549

 

Related Articles

  • Pacific Bio secures $100 million; Elemé Medical raises $18 million.  // Medical Device Daily;7/16/2008, Vol. 12 Issue 136, p2 

    The article reports on the finances of Elemé Medical and Pacific Biosciences. A $100 million Series E private equity financing was secured by Pacific Biosciences, proceeds of which will be used for developing a single-molecule, real-time (SMRT) DNA sequencing platform. L Capital Partners...

  • H&Q Healthcare Investors Declares Stock Distribution.  // Biomedical Market Newsletter;8/15/2012, Vol. 21, p1 

    The article informs that H&Q Healthcare Investors, a closed-end fund which invests in the public and private companies in the healthcare industry, has declared a stock distribution of 0.36 U.S. dollars per share and will be payable by September 28, 2012. It informs that Tekla Capital Management...

  • H&Q Life Sciences Investors Announces Special Meeting of Shareholders.  // Biomedical Market Newsletter;4/30/2011, p734 

    The article reports on the plan of the H&Q Life Sciences Investors to hold a special meeting of the shareholders for the amendment of the Declaration Trust in Boston, Massachusetts.

  • H&Q Healthcare Investors Declares Stock Distribution.  // Biomedical Market Newsletter;8/28/2012, Vol. 21, p1 

    The article informs that the company H&Q Healthcare Investors declared a stock distribution of 0.36 dollar per share. The record date for the stock distribution is August 22, 2012 and the payable date is September 28, 2012. Tekla Capital Management LLC will serve as the investment adviser to the...

  • H&Q Life Sciences Investors Pays Stock Distribution.  // Biomedical Market Newsletter;4/7/2012, Vol. 21, p1 

    The article focuses on the company H&Q Life Sciences' investors who will pay the quarterly stock distribution.

  • H&Q Life Sciences Investors Announces Special Meeting of Shareholders.  // Biomedical Market Newsletter;5/21/2011, p958 

    The article announces that the H & Q Life Science Investors' special meeting of shareholders in Boston will be held on May 2, 2011 rather than on May 3, 2011.

  • Hambrecht & Quist Capital Management LLC Announces Name Change.  // Biomedical Market Newsletter;6/25/2012, Vol. 21, p1 

    The article informs that name of Hambrecht and Quist Capital Management LLC has been changed to Tekla Capital Management LLC.

  • Simparel Receives $4 Million in Financing.  // Apparel Magazine;Aug2008, Vol. 49 Issue 12, p22 

    The article reports that Simparel, a developer of new enterprise resource planning (ERP) solutions, has received $4 million in a Series A round of financing from L Capital Partners L.P. Simparel has also announced that it is rolling out software as a service (SaaS) to selected customers....

  • Abenex, L Capital Sell Stakes In Nutrition & Santé. Foreman, Katya // WWD: Women's Wear Daily;1/7/2009, Vol. 197 Issue 3, p13 

    The article focuses on the declaration by Abenex Capital and L Capital that they have already sold their stakes in Nutrition & Santé to Japan's Otsuka Pharmaceutical Co. Ltd. Abenex Capital and L Capital, accordingly, is a private equity fund sponsored by Groupe Arnault and LVMH Mooet...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics